InVivo Therapeutics' neuro-spinal scaffold device is designed to reduce paralysis symptoms resulting from acute spinal cord injury, according to MoneyShow.
Spinal Tech
Belgium-based Bone Therapeutics reported the 12-month efficacy results from the PREOB Phase IIA severe osteoporosis trial.
BioPoly received the CE mark for its BioPoly RS Partial Resurfacing Shoulder System.
Stryker Director Ronda E. Stryker sold 12,000 shares of the company's stock in a recent transaction, according to a South Florida Hedge Fund Managers report.
Amedica shares fell 12.95 percent in short interest, according to Clinton Financial.
Advertisement
During the fourth quarter, Segall Bryant Hamill bought up to 16,097 Orthofix International shares, according to Street Edition.
Melbourne, Australia-based ARC Center of Excellence for Electromaterials Science researchers developed a biopen for stem cell therapy, according to Forbes.
NuVasive's short interest saw an increase of 26.2 percent between Feb. 29 and March 15, according to a Financial Market News report.
Anika Therapeutics has received CE Mark approval for CINGAL.
Carestream showcased its Carestream OnsSight 3D Extremity System that uses cone beam CT technology to capture weight-bearing and other types of extremity exams at the 2016 American Academy of Orthopaedic Surgeons Annual Meeting, according to Pharmabiz.